Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 983

1.

Reply to: Is the modified disease activity score superior to the disease activity score: A study in early arthritis and rheumatoid arthritis.

Baker JF, Conaghan PG, Smolen JS, Aletaha D, Shults J, Emery P, Baker DG, Ostergaard M.

Arthritis Rheumatol. 2014 Aug 6. doi: 10.1002/art.38810. [Epub ahead of print] No abstract available.

PMID:
25132673
[PubMed - as supplied by publisher]
2.

Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example.

Landewé RB, Smolen JS, Weinblatt ME, Emery P, Dougados M, Fleischmann R, Aletaha D, Kavanaugh A, van der Heijde D.

Ann Rheum Dis. 2014 Aug 11. pii: annrheumdis-2014-205821. doi: 10.1136/annrheumdis-2014-205821. [Epub ahead of print]

PMID:
25114058
[PubMed - as supplied by publisher]
3.

Biologics in rheumatoid arthritis: where are we going?

Fechtenbaum M, Nam JL, Emery P.

Br J Hosp Med (Lond). 2014 Aug;75(8):448-56. doi: 10.12968/hmed.2014.75.8.448.

PMID:
25111096
[PubMed - in process]
4.

Biologics in systemic lupus erythematosus: current options and future perspectives.

Yusof MY, Vital EM, Emery P.

Br J Hosp Med (Lond). 2014 Aug;75(8):440-7. doi: 10.12968/hmed.2014.75.8.440.

PMID:
25111095
[PubMed - in process]
5.

Systematic review: the effect of prunes on gastrointestinal function.

Lever E, Cole J, Scott SM, Emery PW, Whelan K.

Aliment Pharmacol Ther. 2014 Aug 11. doi: 10.1111/apt.12913. [Epub ahead of print]

PMID:
25109788
[PubMed - as supplied by publisher]
6.

Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years.

Baker JF, Ostergaard M, George M, Shults J, Emery P, Baker DG, Conaghan PG.

Ann Rheum Dis. 2014 Aug 4. pii: annrheumdis-2014-205544. doi: 10.1136/annrheumdis-2014-205544. [Epub ahead of print]

PMID:
25091439
[PubMed - as supplied by publisher]
7.

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.

van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EW, Vonk MC, Schattenberg AV, Matucci-Cerinic M, Voskuyl AE, van de Loosdrecht AA, Daikeler T, Kötter I, Schmalzing M, Martin T, Lioure B, Weiner SM, Kreuter A, Deligny C, Durand JM, Emery P, Machold KP, Sarrot-Reynauld F, Warnatz K, Adoue DF, Constans J, Tony HP, Del Papa N, Fassas A, Himsel A, Launay D, Lo Monaco A, Philippe P, Quéré I, Rich É, Westhovens R, Griffiths B, Saccardi R, van den Hoogen FH, Fibbe WE, Socié G, Gratwohl A, Tyndall A; EBMT/EULAR Scleroderma Study Group.

JAMA. 2014 Jun 25;311(24):2490-8. doi: 10.1001/jama.2014.6368.

PMID:
25058083
[PubMed - indexed for MEDLINE]
8.

Collagenous colitis in systemic sclerosis: an overlooked and treatable complication.

Abignano G, Scott N, Wollheim FA, Emery P, Buch MH, Del Galdo F.

J Clin Rheumatol. 2014 Aug;20(5):278-82. doi: 10.1097/RHU.0000000000000121.

PMID:
25036565
[PubMed - in process]
9.

Long-term safety and efficacy of abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 7-year extended study.

Westhovens R, Kremer JM, Emery P, Russell AS, Alten R, Barré E, Dougados M.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4):553-62. Epub 2014 Jul 8.

PMID:
25005467
[PubMed - in process]
10.

Efficacy of golimumab plus methotrexate in methotrexate-naïve patients with severe active rheumatoid arthritis.

Emery P, Fleischmann RM, Hsia EC, Xu S, Zhou Y, Baker D.

Clin Rheumatol. 2014 Jul 9. [Epub ahead of print]

PMID:
25005327
[PubMed - as supplied by publisher]
11.

Diurnal variation of gait in patients with rheumatoid arthritis: The DIVIGN study.

Backhouse MR, Pickles DA, Mathieson HR, Edgson L, Emery P, Helliwell PS, Redmond AC.

Clin Biomech (Bristol, Avon). 2014 Jun 2. pii: S0268-0033(14)00128-4. doi: 10.1016/j.clinbiomech.2014.05.009. [Epub ahead of print]

PMID:
24954102
[PubMed - as supplied by publisher]
Free Article
12.

Defining populations at risk of rheumatoid arthritis: the first steps to prevention.

Hunt L, Emery P.

Nat Rev Rheumatol. 2014 Jun 17. doi: 10.1038/nrrheum.2014.82. [Epub ahead of print]

PMID:
24934191
[PubMed - as supplied by publisher]
13.

Comment on the article "low versus high dose rituximab for rheumatoid arthritis: A systematic review and meta-analysis" by Bredemeier et al.

Vital EM, Md Yusof MY, Emery P.

Arthritis Care Res (Hoboken). 2014 Jun 6. doi: 10.1002/acr.22379. [Epub ahead of print] No abstract available.

PMID:
24905770
[PubMed - as supplied by publisher]
14.

Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry results.

Juarez M, Toms TE, de Pablo P, Mitchell S, Bowman S, Nightingale P, Price EJ, Griffiths B, Hunter J, Gupta M, Bombardieri M, Sutdliffe N, Pitzalis C, Pease C, Andrews J, Emery P, Regan M, Giles I, Isenberg D, Moots R, Collins KS, Ng WF, Kitas GD; UK Primary Sjögren’s Syndrome Registry.

Arthritis Care Res (Hoboken). 2014 May;66(5):757-64.

PMID:
24877201
[PubMed - indexed for MEDLINE]
15.

What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort.

Takase K, Horton SC, Ganesha A, Das S, McHugh A, Emery P, Savic S, Buch MH.

Ann Rheum Dis. 2014 Sep;73(9):1695-9. doi: 10.1136/annrheumdis-2014-205318. Epub 2014 May 22.

PMID:
24854356
[PubMed - in process]
16.

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology.

Buch MH, Silva-Fernandez L, Carmona L, Aletaha D, Christensen R, Combe B, Emery P, Ferraccioli G, Guillemin F, Kvien TK, Landewe R, Pavelka K, Saag K, Smolen JS, Symmons D, van der Heijde D, Welling J, Wells G, Westhovens R, Zink A, Boers M.

Ann Rheum Dis. 2014 May 14. pii: annrheumdis-2013-204948. doi: 10.1136/annrheumdis-2013-204948. [Epub ahead of print]

PMID:
24827533
[PubMed - as supplied by publisher]
Free Article
17.

Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial.

Kremer JM, Peterfy C, Russell AS, Emery P, Abud-Mendoza C, Sibilia J, Becker JC, Westhovens R, Genant HK.

J Rheumatol. 2014 Jun;41(6):1077-87. doi: 10.3899/jrheum.130263. Epub 2014 May 1.

PMID:
24786925
[PubMed - in process]
Free Article
18.

Autoantibodies to posttranslational modifications in rheumatoid arthritis.

Burska AN, Hunt L, Boissinot M, Strollo R, Ryan BJ, Vital E, Nissim A, Winyard PG, Emery P, Ponchel F.

Mediators Inflamm. 2014;2014:492873. doi: 10.1155/2014/492873. Epub 2014 Mar 23.

PMID:
24782594
[PubMed - in process]
Free PMC Article
19.

Is the glass half full or half empty? Comment on the article by Gärtner et Al.

Ikeda K, Koike T, Wakefield R, Emery P.

Arthritis Rheumatol. 2014 Apr;66(4):1055-6. doi: 10.1002/art.38321. No abstract available.

PMID:
24757158
[PubMed - indexed for MEDLINE]
20.

Development and validation of modified disease activity scores in rheumatoid arthritis: superior correlation with magnetic resonance imaging-detected synovitis and radiographic progression.

Baker JF, Conaghan PG, Smolen JS, Aletaha D, Shults J, Emery P, Baker DG, Ostergaard M.

Arthritis Rheumatol. 2014 Apr;66(4):794-802. doi: 10.1002/art.38304.

PMID:
24757132
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk